SS31 Ameliorates Oxidative Stress via the Restoration of Autophagic Flux to Protect Aged Mice From Hind Limb Ischemia

Qiaoyun Yang; Chunqiu Li; Qingwei Chen

doi:10.3389/fcvm.2022.789331

journal article Open Access Apr 14, 2022

SS31 Ameliorates Oxidative Stress via the Restoration of Autophagic Flux to Protect Aged Mice From Hind Limb Ischemia

Qiaoyun Yang Chunqiu Li Qingwei Chen

Frontiers in Cardiovascular Medicine Vol. 9 · Frontiers Media SA

View at Publisher Save 10.3389/fcvm.2022.789331

Abstract

BackgroundOxidative stress and impaired autophagic flux play important roles in the development of peripheral artery disease (PAD). SS31 is considered an important antioxidant peptide and autophagy regulator. We aimed to investigate the role of SS31 in PAD myopathy and its possible mechanism both in vivo and in vitro.MethodsA hind limb ischemia (HLI) model was established with old C57BL/6 (14-month-old) mice. Mice in the SS31 group were intraperitoneally injected with SS31 (3 mg/kg) for 4 weeks. We examined skeletal muscle function and histomorphology, autophagy-related protein levels and reactive oxygen species (ROS) content. For the in vitro experiments, after C2C12 myotubes were treated with CoCl2, SS31, and chloroquine (CQ) or rapamycin (RAPA), we measured ROS content, autophagy-related protein levels and antioxidant enzyme expression.ResultsSS31 treatment effectively enhanced the recovery of skeletal muscle function, alleviated skeletal muscle injury and suppressed mitochondrial ROS production in ischemic limbs. SS31 reduced apoptosis and oxidative stress, and SS31 restored impaired autophagic flux by inhibiting the AKT-mTOR pathway. In vitro studies showed that SS31 restored autophagic flux and improved oxidative stress in C2C12 cells. Moreover, phosphorylated AKT (p-AKT) and phosphorylated mTOR (p-mTOR) levels were reduced.ConclusionThese experiments indicated that SS31 can inhibit oxidative stress by restoring autophagic flux to reverse hypoxia-induced injury in vivo and in vitro.

Topics

No keywords indexed for this article. Browse by subject →

References

40

[1]

Cooke "A compendium on peripheral arterial disease." Circ Res. (2015) 10.1161/circresaha.115.306403

[2]

Leeper "Genetics of peripheral artery disease." Circulation. (2012) 10.1161/circulationaha.111.033878

[3]

Teraa "Critical limb ischemia: current trends and future directions." J Am Heart Assoc. (2016) 10.1161/jaha.115.002938

[4]

Ismaeel "Oxidative stress and arterial dysfunction in peripheral artery disease." Antioxidants. (2018) 10.3390/antiox7100145

[5]

Pipinos "The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction." Vasc Endovasc Surg. (2007) 10.1177/1538574407311106

[6]

Steven "Peripheral artery disease, redox signaling, oxidative stress – basic and clinical aspects." Redox Biol. (2017) 10.1016/j.redox.2017.04.017

[7]

Signorelli "Oxidative stress in peripheral arterial disease (PAD) mechanism and biomarkers." Antioxidants (Basel). (2019) 10.3390/antiox8090367

[8]

Signorelli "Pathophysiology of chronic peripheral ischemia: new perspectives." Ther Adv Chronic Dis. (2020) 10.1177/2040622319894466

[9]

He "Exercise enhances mitochondrial fission and mitophagy to improve myopathy following critical limb ischemia in elderly mice via the PGC1a/FNDC5/irisin pathway." Skelet Muscle. (2020) 10.1186/s13395-020-00245-2

[10]

Gerhard-Herman "2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines." Circulation. (2017) 10.1161/cir.0000000000000471

[11]

Fowkes "Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis." Lancet. (2013) 10.1016/s0140-6736(13)61249-0

[12]

An Overview of Autophagy: Morphology, Mechanism, and Regulation

Katherine R. Parzych, Daniel J. Klionsky

Antioxidants & Redox Signaling 2014 10.1089/ars.2013.5371

[13]

Cheng "Therapeutic targeting of autophagy in disease: biology and pharmacology." Pharmacol Rev. (2013) 10.1124/pr.112.007120

[14]

Liang "Therapeutic efficacy of apelin on transplanted mesenchymal stem cells in hindlimb ischemic mice via regulation of autophagy." Sci Rep. (2016) 10.1038/srep21914

[15]

Schiattarella "Therapeutic targeting of autophagy in cardiovascular disease." J Mol Cell Cardiol. (2016) 10.1016/j.yjmcc.2015.11.019

[16]

BAG3 (Bcl-2–Associated Athanogene-3) Coding Variant in Mice Determines Susceptibility to Ischemic Limb Muscle Myopathy by Directing Autophagy

Joseph M. McClung, Timothy J. McCord, Terence E. Ryan et al.

Circulation 2017 10.1161/circulationaha.116.024873

[17]

Birk "The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin." J Am Soc Nephrol. (2013) 10.1681/asn.2012121216

[18]

Dai "Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy." J Am Coll Cardiol. (2011) 10.1016/j.jacc.2010.12.044

[19]

Szeto "Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury." Antioxid Redox Signal. (2008) 10.1089/ars.2007.1892

[20]

Zhao "Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury." J Biol Chem. (2004) 10.1074/jbc.m402999200

[21]

Cho "A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36." J Biol Chem. (2007) 10.1074/jbc.m609388200

[22]

Wyss "Differential effects of the mitochondria-active tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH) and its peptidase-targeted prodrugs in experimental acute kidney injury." Front Pharmacol. (2019) 10.3389/fphar.2019.01209

[23]

Thomas "Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function." J Am Soc Nephrol. (2007) 10.1681/asn.2006080825

[24]

Zhang "Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats." J Nanobiotechnol. (2019) 10.1186/s12951-019-0451-9

[25]

Paradis "Aging exacerbates ischemia-reperfusion-induced mitochondrial respiration impairment in skeletal muscle." Antioxidants (Basel). (2019) 10.3390/antiox8060168

[26]

Campbell "Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice." Free Radic Biol Med. (2019) 10.1016/j.freeradbiomed.2018.12.031

[27]

McDermott "Skeletal muscle pathology in peripheral artery disease: a brief review." Arterioscler Thromb Vasc Biol. (2020) 10.1161/atvbaha.120.313831

[28]

Gratl "The effect of revascularization on recovery of mitochondrial respiration in peripheral artery disease: a case control study." J Transl Med. (2021) 10.1186/s12967-021-02908-0

[29]

Enhanced autophagy alleviates injury during hindlimb ischemia/reperfusion in mice

Chenshu Liu, Meixiu Peng, Liang Zheng et al.

Experimental and Therapeutic Medicine 2019 10.3892/etm.2019.7743

[30]

Ischemia induces autophagy of endothelial cells and stimulates angiogenic effects in a hindlimb ischemia mouse model

In-Hye Jeong, Woom-Yee Bae, Jae-Sun Choi et al.

Cell Death & Disease 2020 10.1038/s41419-020-02849-4

[31]

Fan "Endothelial deletion of mTORC1 protects against hindlimb ischemia in diabetic mice via activation of autophagy, attenuation of oxidative stress and alleviation of inflammation." Free Radic Biol Med. (2017) 10.1016/j.freeradbiomed.2017.05.001

[32]

Margeta "Autophagy defects in skeletal myopathies." Annu Rev Pathol. (2020) 10.1146/annurev-pathmechdis-012419-032618

[33]

Schiaffino "Mechanisms regulating skeletal muscle growth and atrophy." FEBS J. (2013) 10.1111/febs.12253

[34]

Risson "Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy." J Cell Biol. (2009) 10.1083/jcb.200903131

[35]

A New Murine Model of Sustainable and Durable Chronic Critical Limb Ischemia Fairly Mimicking Human Pathology

A. Lejay, P. Choquet, F. Thaveau et al.

European Journal of Vascular and Endovascular Surg... 2015 10.1016/j.ejvs.2014.12.010

[36]

Lee "Combined therapy with SS31 and mitochondria mitigates myocardial ischemia-reperfusion injury in rats." Int J Mol Sci. (2018) 10.3390/ijms19092782

[37]

Liu "ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule." Sci Adv. (2020) 10.1126/sciadv.abb7422

[38]

Rodney "Redox regulation of autophagy in skeletal muscle." Free Radic Biol Med. (2016) 10.1016/j.freeradbiomed.2016.05.010

[39]

Smuder "Crosstalk between autophagy and oxidative stress regulates proteolysis in the diaphragm during mechanical ventilation." Free Radic Biol Med. (2018) 10.1016/j.freeradbiomed.2017.11.025

[40]

Montalvo "Doxorubicin-induced oxidative stress differentially regulates proteolytic signaling in cardiac and skeletal muscle." Am J Physiol Regul Integr Comp Physiol. (2020) 10.1152/ajpregu.00299.2019

Metrics

6

Citations

40

References

Details

Published: Apr 14, 2022
Vol/Issue: 9
License: View

Authors

Cite This Article

Qiaoyun Yang, Chunqiu Li, Qingwei Chen (2022). SS31 Ameliorates Oxidative Stress via the Restoration of Autophagic Flux to Protect Aged Mice From Hind Limb Ischemia. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.789331

SS31 Ameliorates Oxidative Stress via the Restoration of Autophagic Flux to Protect Aged Mice From Hind Limb Ischemia

You May Also Like